<label id="mboud"><meter id="mboud"></meter></label>

        <rt id="mboud"><small id="mboud"><strike id="mboud"></strike></small></rt>
        咨詢熱線

        15000266580

        當前位置:首頁 >產品中心>細胞庫>人腫瘤細胞、癌細胞>CRL-2557Panc 05.04 人胰腺癌細胞

        Panc 05.04 人胰腺癌細胞

        簡要描述:CRL-2557 Panc 05.04 人胰腺癌細胞,
        原代細胞|細胞系|細胞株|菌種;細胞庫管理規范,
        提供的細胞株背景清楚,提供參考文獻和培養條件!

        • 產品型號:CRL-2557
        • 廠商性質:生產廠家
        • 更新時間:2025-07-19
        • 訪  問  量:2126

        產品分類

        Product Category

        詳細介紹

        CRL-2557 Panc 05.04 人胰腺癌細胞

        ATCC® Number: CRL-2557™ Price: $417.00

        Designations: Panc 05.04

        Depositors: EM Jaffee

        Biosafety Level: 1

        Shipped: frozen

        Medium & Serum: See Propagation

        Growth Properties: adherent

        Organism: Homo sapiens (human)

        Morphology: epithelial

        Source: Organ: pancreas

        Disease: adenocarcinoma

        Cellular Products: cytokeratins 7 and 18 [50655]

        Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


        CRL-2557 Panc 05.04 人胰腺癌細胞

        Isolation: Isolation date: May 5, 1995

        Tumorigenic: Yes

        Oncogene: K-ras +

        Antigen Expression: MHC class I +; MHC class II - [50655]

        Blood type B; Rh+

        Age: 77 years adult

        Gender: female

        Ethnicity: White

        Comments: Panc 05.04 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma.

        The cell line exhibits a K-ras oncogene mutation at codon 12 where a GGT --> GAT mutation resulted in substitution of aspartic acid for glycine. [50655]

        The cells have a reported plating efficiency of 100%. [50655]

        Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 20 Units/ml human recombinant insulin, 85%; fetal bovine serum, 15%

        Atmosphere: air, 95%; carbon dioxide (CO2), 5%

        Temperature: 37.0°C

        Subculturing: Protocol:

        1.Remove and discard culture medium.

        2.Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.

        3.Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

        Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

        4.Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

        5.To remove trypsin-EDTA solution, transfer cell suspension to centrifuge tube and spin at approximay 125 xg for 5 to 10 minutes.Discard supernatant and resuspend cells in fresh growth medium. Add appropriate aliquots of cell suspension to new culture vessels.

        6.Incubate cultures at 37°C.

        Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:5 is recommended

        Medium Renewal: Add media once per week. Fluid change one to two times per week.

        Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO

        Storage temperature: liquid nitrogen vapor phase

        Doubling Time: 46 hrs

        Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

        recommended serum:ATCC 30-2020

        References: 50655: Jaffee EM, et al. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4: 194-203, 1998. PubMed: 9612602

        CRL-2557


















        產品咨詢

        留言框

        • 產品:

        • 您的單位:

        • 您的姓名:

        • 聯系電話:

        • 常用郵箱:

        • 省份:

        • 詳細地址:

        • 補充說明:

        • 驗證碼:

          請輸入計算結果(填寫阿拉伯數字),如:三加四=7
        聯系方式

        郵箱:xiangfbio@163.com

        地址:上海市虹口區四平路710號7層

        咨詢熱線

        400-821-8510

        (周一至周日9:00- 19:00)

        在線咨詢
        • 掃一掃 微信咨詢

        Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
        技術支持:化工儀器網    管理登陸
        主站蜘蛛池模板: 国产偷伦视频免费观看| 亚洲美女大bbbbbbbbb| 国产成人亚洲精品蜜芽影院| 青青在线久青草免费观看| 亚洲91av视频| 久久免费视频网站| 久久亚洲日韩看片无码| **aaaaa毛片免费同男同女| 亚洲系列中文字幕| 国国内清清草原免费视频99| 亚洲综合久久精品无码色欲| 97无码免费人妻超级碰碰碰碰| 亚洲无线电影官网| 午夜无码A级毛片免费视频| 久久精品国产亚洲AV果冻传媒| 暖暖在线视频免费视频| 免费高清小黄站在线观看| 亚洲国产欧美一区二区三区| 毛片免费vip会员在线看| 国产亚洲精品国产福利在线观看 | 无码国产精品一区二区免费16| 亚洲情a成黄在线观看动漫尤物| 精品无码国产污污污免费网站 | 成人毛片18女人毛片免费96| 国产精品亚洲综合| 亚洲欧洲成人精品香蕉网| 日本在线免费观看| www.亚洲日本| 亚洲精品国产V片在线观看| 两个人日本免费完整版在线观看1| 亚洲午夜视频在线观看| 在线免费不卡视频| 国产乱妇高清无乱码免费| 亚洲男人天堂av| 精品国产免费一区二区| CAOPORM国产精品视频免费| 亚洲性色高清完整版在线观看| 亚洲色中文字幕无码AV| h视频在线观看免费完整版| MM1313亚洲国产精品| 久久亚洲AV午夜福利精品一区|